- 14.5hrs
- Public
- Version: 1
- Review due: October 2025
New
The Pharmacy anti-cancer drug course supports pharmacists to develop the knowledge and clinical skills required to work safely with anti-cancer drugs and the patients receiving them.
About
The Pharmacy anti-cancer drug course provides foundation level education for pharmacists working in the cancer care practice setting.
The course consists of online learning and practical skills development to support the translation of theory into practice within the workplace. Competency assessments are used to assess clinical skill.
There are two models of course delivery that can be adapted to suit the needs of the learner and the workplace.
Self-directed model
- The learner completes the online components of the course only including eLearning guides, eQuizzes and workbooks (optional).
Facilitator model
- The learner completes the online components of the course including the eLearning guides, eQuizzes and workbooks (optional).
- A trained pharmacy anti-cancer drug course facilitator supports the learner to complete the practical skills components of the course including supervised clinical practice, clinical skills workshop and competency assessments.
Modules
Workbooks have been provided to assist you in applying the principles discussed in the modules to your local work context and role. If you choose to use the workbook, whenever you see a workplace reflection in the module, there is space allocated in the workbook for you to record notes. Please confirm with your local supervisor or facilitator (if available) if the workbook is mandated at your workplace.
This module provides an overview of the characteristics of hazardous drugs and principles of risk management in the workplace, including the safe handling of hazardous drugs and related waste, and the management of risk and exposure in the workplace.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an overview of the common side effects and supportive care measures associated with anti-cancer drug treatment.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an overview of the common side effects and supportive care measures associated with anti-cancer drug treatment.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an introduction to the principles for supporting safe administration of anti-cancer drugs and the role of the pharmacist in supporting these processes in the workplace.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an introduction to medication safety and clinical governance principles essential to pharmacists working with anti-cancer drugs.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an introduction to the essential components of anti-cancer drug treatment prescriptions, including an overview of a structured process for conducting clinical verification of anti-cancer treatment prescriptions.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an outline of the priorities in providing education to patients receiving anti-cancer drugs an carers administering them in the home environment.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
Additional Information
Modules may be completed in any order and may be prioritised according to your role and responsibilities.
These seven modules have been accredited for 14.5 hours of Group 1 CPD activity (or 14.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 14.5 hours of Group 2 CPD (or 29 CPD credits) upon successful completion of the relevant assessment activity.
Each module is accredited as listed below. The accredited activities for each module include the eLearning guide and eQuiz only. The workbooks, clinical skills workshop and competency assessments are not accredited activities under the accreditations below.
| Resource name |
Accreditation |
CPD allocation |
| Safe Handling of hazardous drugs and related waste |
S2023/68 |
2 CPD credits (Group 1), convertible to 4 CPD credits (Group 2)* |
| Understanding how anti-cancer drugs work |
S2023/76 |
2.25 CPD credits (Group 1), convertible to 4.5 CPD credits (Group 2)* |
| Treatment-related toxicities and management |
S2023/84 |
3.25 CPD credits (Group 1), convertible to 6.5 CPD credits (Group 2)* |
| Principles of supporting the administration of anti-cancer drugs |
S2023/85 |
1.75 CPD credits (Group 1), convertible to 3.5 CPD credits (Group 2)* |
| Medication safety and clinical governance principles for cancer pharmacists |
S2023/86 |
2.25 CPD credits (Group 1), convertible to 4.5 CPD credits (Group 2)* |
| Clinical verification of anti-cancer treatment prescriptions |
S2023/87 |
1.75 CPD credits (Group 1), convertible to 3.5 CPD credits (Group 2)* |
| Patient education |
S2023/88 |
1.25 CPD credits (Group 1), convertible to 2.5 CPD credits (Group 2)* |
*These seven modules have been accredited for Group 1 CPD activity suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to Group 2 CPD upon successful completion of the relevant assessment activity.
This course addresses National Competency Standards 2016.
Endorsed by:
The International Society of Oncology Pharmacy Practitioners (ISOPP) aims to advance oncology pharmacy care for patients around the world, and connects oncology pharmacy experts to leading edge oncology knowledge, best practices and essential networks.